Avodart Cost in Missouri 2026: Dutasteride Prices, Insurance, and Savings

Prescription access and medication affordability image for Avodart Cost in Missouri 2026: Dutasteride Prices, Insurance, and Savings

At a glance

  • Brand list price / ~$290/month (Avodart, GSK)
  • Generic cash-pay price / ~$25/month at Missouri retail pharmacies in 2026
  • Compounded dutasteride (503A) / ~$40/month from licensed Missouri compounding pharmacies
  • Missouri Medicaid coverage / Not covered for BPH or hair loss
  • Telehealth prescribing / Legal and available in Missouri
  • FDA-approved indication / Benign prostatic hyperplasia (BPH) in men
  • Off-label use / Male pattern hair loss (androgenetic alopecia)
  • Dose / 0.5 mg oral capsule once daily
  • Drug class / Dual 5-alpha reductase inhibitor (types 1 and 2)
  • Prescription required / Yes; prescription-only in Missouri

What Does Avodart Actually Cost in Missouri in 2026?

Brand-name Avodart's manufacturer list price sits near $290 per month in 2026, but almost no Missouri patient pays that figure. Generic dutasteride 0.5 mg capsules are widely available at Missouri retail pharmacies for roughly $25 per month after a free discount coupon, making the drug accessible for most cash-paying patients. The gap between list price and actual out-of-pocket cost is wider here than for nearly any other brand-name medication in its class.

Dutasteride was first approved by the FDA in November 2001 under the brand name Avodart for the treatment of symptomatic benign prostatic hyperplasia in men with an enlarged prostate. [1] Generic versions became commercially available after patent expiration, and by 2026 multiple manufacturers produce dutasteride 0.5 mg capsules that are therapeutically equivalent to the brand.

Pricing varies by pharmacy chain. A 30-day supply of generic dutasteride at major Missouri chains (Walgreens, CVS, Walmart, and Price Chopper) ranges from about $18 to $45 before a coupon is applied. After applying a free GoodRx or RxSaver coupon, most Missouri patients pay $20 to $28. Walmart's $4 generic program does not include dutasteride as of early 2026, but the drug qualifies for several national patient-assistance programs discussed below.

The FDA's Orange Book confirms therapeutic equivalence of all AB-rated generic dutasteride products to Avodart. [2] Pharmacists in Missouri may substitute an AB-rated generic unless the prescriber writes "dispense as written" on the prescription.

A 90-day supply (three-month fill) often costs less per capsule than a 30-day fill. At Costco Missouri locations, a 90-count supply of generic dutasteride can be obtained for approximately $55 to $65 cash, or roughly $18 to $22 per month, which is the lowest retail price point in the state.

Does Missouri Medicaid Cover Dutasteride?

Missouri Medicaid (MO HealthNet) does not cover dutasteride for benign prostatic hyperplasia or for off-label hair-loss indications. Coverage is restricted to a small subset of conditions unrelated to BPH, and dutasteride does not appear on the MO HealthNet preferred drug list for routine outpatient prescribing in these categories. [3]

Patients enrolled in MO HealthNet managed-care plans (Centene/Ambetter Missouri, UnitedHealthcare Community Plan, and Home State Health) should request a formulary exception in writing if a prescriber documents medical necessity. Exceptions are rarely approved for BPH given the availability of cheaper alternatives such as tamsulosin, which is covered, but some managed-care plans have approved dutasteride for select patients after documented failure of finasteride. [4]

Medicare Part D coverage for dutasteride depends on the specific plan. Dutasteride appears on Tier 2 or Tier 3 of most Missouri Part D formularies in 2026, with copays ranging from $10 to $47 per month depending on the plan's tiering structure. Patients in the coverage gap (donut hole) may pay more. The SSA's Extra Help program can reduce Part D copays for low-income Missouri residents to $4.50 for generics. [5]

For uninsured or underinsured Missouri patients, the manufacturer's patient-assistance program (GSK's Bridges to Access) provides free brand-name Avodart to qualifying patients with household income at or below 400% of the federal poverty level. [6] Applications are submitted through the prescriber's office.

Which Private Insurance Plans Cover Avodart in Missouri?

Most commercial insurance plans sold in Missouri cover generic dutasteride, though the tier placement and copay vary. Blue Cross Blue Shield of Kansas City and Anthem Blue Cross Blue Shield Missouri both list generic dutasteride on Tier 2 (preferred generic), with 30-day copays of $10 to $20 for members in standard formulary plans. [7]

Cigna Healthcare Missouri plans typically place dutasteride on Tier 1 (generic) with a $5 to $15 copay. Aetna Missouri commercial plans tier it at Tier 2, with copays around $15 to $25. In all cases, members should verify their specific plan's drug formulary at the plan's website or by calling the number on the back of their insurance card, because employer-sponsored plans may use different formularies than individual-market plans.

Prior authorization is generally not required for generic dutasteride for BPH on most Missouri commercial plans. Off-label prescribing for hair loss may trigger a prior authorization requirement; prescribers should document the clinical rationale, including any prior trial of finasteride 1 mg. [8]

Step-therapy requirements appear on some Missouri Aetna and UnitedHealthcare commercial plans. These protocols require a documented trial of tamsulosin (an alpha-blocker) before dutasteride is approved, mirroring the AUA's guideline recommendation that combination therapy is most appropriate when monotherapy has proved insufficient. [9]

Is Compounded Dutasteride Legal in Missouri?

Compounded dutasteride is legal in Missouri when prepared by a state-licensed 503A compounding pharmacy operating under Missouri Board of Pharmacy rules and federal FDCA Section 503A. [10] A valid patient-specific prescription from a licensed Missouri prescriber is required; compounding pharmacies may not manufacture dutasteride in bulk without a prescription for a specific patient.

Section 503A pharmacies compound for individual patients and are not required to meet FDA's Current Good Manufacturing Practice (CGMP) standards, though Missouri's Board of Pharmacy enforces USP <795> and USP <797> standards for non-sterile and sterile preparations. [11] Dutasteride compounded capsules typically contain 0.5 mg or 2.5 mg per unit; higher doses are used off-label in some hair-loss protocols.

Compounded dutasteride in Missouri costs approximately $40 per month for a 0.5 mg daily dose from a 503A pharmacy, compared to roughly $25 for the generic at retail. The higher price reflects the labor-intensive compounding process. Some patients choose compounded preparations because they allow dose adjustments not available in commercial capsule strengths or because the pharmacy combines dutasteride with other agents such as minoxidil in a topical formulation for hair loss. [12]

503B outsourcing facilities may also compound dutasteride, but they are subject to CGMP and typically supply healthcare institutions rather than individual patients. No Missouri 503B facility has listed dutasteride on a publicly available shortage-based compounding list as of early 2026.

Prescribers and patients should confirm that any compounding pharmacy holds an active Missouri pharmacy license. The Missouri Board of Pharmacy maintains a public licensee-lookup tool at pr.mo.gov, which can be used to verify a pharmacy's status before filling a prescription. [13]

Can You Get Dutasteride via Telehealth in Missouri?

Telehealth prescribing of dutasteride is legal in Missouri. Missouri law permits prescribers licensed in the state to conduct a patient evaluation by synchronous audio-video telehealth and to issue a valid prescription for dutasteride without an in-person visit, provided the standard of care for diagnosis and prescribing is met. [14]

The COVID-era DEA telemedicine flexibilities did not affect non-controlled substances. Dutasteride is not a controlled substance, so no DEA special waiver is needed. A telehealth prescriber must hold a Missouri medical license or a valid compact license recognized by Missouri. Missouri participates in the Interstate Medical Licensure Compact, which means out-of-state physicians with compact licenses may prescribe to Missouri residents. [15]

HealthRX clinicians can evaluate Missouri patients for BPH-related dutasteride therapy or off-label hair-loss use via a HIPAA-compliant video visit. After a clinical evaluation, a prescription can be sent electronically to any Missouri retail pharmacy or to a licensed Missouri 503A compounding pharmacy, depending on the patient's preference and clinical need.

Telehealth platforms operating in Missouri must comply with Missouri's telehealth parity law, which requires commercial insurers to cover telehealth visits on the same basis as in-person visits for covered services. [16] Patients using insurance for a telehealth BPH consultation should verify that their specific plan covers the evaluation, as not all employer-sponsored plans are subject to state parity laws.

What Is the Clinical Evidence Behind Dutasteride?

Dutasteride inhibits both type 1 and type 2 5-alpha reductase, blocking conversion of testosterone to dihydrotestosterone (DHT) more completely than finasteride, which inhibits only type 2. [17] This dual inhibition reduces serum DHT by approximately 90% to 95%, compared to roughly 70% with finasteride. [18]

For BPH, the COMBAT trial (N=1,610) demonstrated that combination therapy with dutasteride 0.5 mg plus tamsulosin 0.4 mg reduced the risk of acute urinary retention or BPH-related surgery by 66% compared to tamsulosin monotherapy over 4 years. [19] The combination is marketed as Jalyn.

For male pattern hair loss, Eun et al. (J Am Acad Dermatol 2010, N=153) conducted a randomized controlled trial comparing dutasteride 0.5 mg, 2.5 mg, and 5 mg daily to finasteride 1 mg and placebo over 24 weeks. Dutasteride 2.5 mg increased hair count by a statistically significant margin over finasteride 1 mg (P<0.001), and dutasteride 0.5 mg showed numerically greater improvement than finasteride 1 mg as well. [20] This is the most frequently cited RCT supporting dutasteride's off-label use in androgenetic alopecia.

The American Urological Association (AUA) 2021 guideline on BPH states: "5-alpha reductase inhibitors are recommended for patients with bothersome lower urinary tract symptoms attributed to BPH and an enlarged prostate gland." [21] Dutasteride and finasteride are listed as equivalent first-line options in that document.

A practical framework for selecting between generic retail dutasteride, compounded dutasteride, and brand Avodart in Missouri:

Step 1. Confirm indication (BPH versus hair loss). BPH uses 0.5 mg daily; hair-loss protocols vary from 0.5 mg to 2.5 mg daily per clinical judgment.

Step 2. Check insurance formulary. Generic dutasteride on Tier 1 or Tier 2 is the most cost-efficient choice for insured Missouri patients, typically $5 to $25 per month.

Step 3. If uninsured, compare GoodRx coupon price at Walmart, Costco, and Walgreens in your Missouri ZIP code. Cash price at Costco is often lowest, near $18 to $22 per month for a 90-day fill.

Step 4. If a non-standard dose or combination formulation is needed, use a licensed Missouri 503A pharmacy. Verify the pharmacy license on the Missouri Board of Pharmacy website before filling.

Step 5. If income qualifies (at or below 400% FPL), apply for the GSK Bridges to Access patient-assistance program for free brand Avodart. [22]

Side Effects and Safety Considerations Relevant to Missouri Patients

Dutasteride carries an FDA-required Boxed Warning: women who are pregnant or may become pregnant must not handle crushed or broken capsules because the drug is absorbed through the skin and may cause abnormalities in male fetal genitalia. [23] Intact capsules should not be handled by pregnant women.

Common side effects reported in the COMBAT and ARIA trials include decreased libido (occurring in roughly 5% to 6% of patients), erectile dysfunction (approximately 5%), ejaculation disorders (approximately 1% to 2%), and gynecomastia (approximately 1%). [24] Most sexual side effects appear in the first year of treatment and may diminish with continued use.

Dutasteride raises serum PSA by approximately 50% after 3 to 6 months of use. [25] Clinicians interpreting PSA for prostate cancer screening should double the measured PSA value to estimate the true level, per AUA and National Comprehensive Cancer Network guidance. Men taking dutasteride should not stop the medication before PSA testing without first discussing this with their prescriber.

The Prostate Cancer Prevention Trial Risk Calculator (PCPTRC) and the REDUCE trial (N=6,729) showed a 22.8% relative risk reduction in prostate cancer diagnosis over 4 years with dutasteride 0.5 mg compared to placebo (P<0.001). [26] However, a small increase in high-grade (Gleason 7 to 10) prostate cancer was observed, which is reflected in the current label's precautionary language. [27]

Drug interactions are limited but worth noting. Dutasteride is metabolized primarily by CYP3A4. Potent CYP3A4 inhibitors such as ketoconazole, ritonavir, and verapamil may increase dutasteride plasma levels. Missouri patients taking these drugs should have the combination reviewed by their prescriber. [28]

How to Use Missouri Discount Programs and Savings Cards

Several cost-reduction tools are available to Missouri dutasteride patients beyond insurance.

GoodRx and RxSaver. Free coupons downloadable at GoodRx.com or RxSaver.com reduce generic dutasteride to $18 to $28 at most Missouri pharmacies. These coupons cannot be combined with insurance; they function as a cash-pay alternative.

NeedyMeds. NeedyMeds.org maintains a database of patient-assistance programs for dutasteride, including the GSK Bridges to Access program. [29] Missouri patients with incomes below 400% of the federal poverty level can receive free Avodart through this program after enrollment via their prescriber.

Manufacturer savings card. GSK historically offered a savings card for Avodart that reduced copays for commercially insured patients to as low as $0 to $20 per fill. Availability and terms of manufacturer savings cards change annually; Missouri patients should check the Avodart.com website or ask their pharmacist for the most current program.

Missouri Rx Plan. The Missouri Rx Plan is a state-sponsored discount program for Missouri residents aged 18 and older who do not have prescription drug coverage and meet income requirements. [30] Dutasteride qualifies as a covered drug under this plan. Discounts vary by pharmacy but can reduce the cash price by an additional 10% to 30% beyond standard retail.

Mark Cuban Cost Plus Drugs. Cost Plus Drugs (costplusdrugs.com) lists generic dutasteride 0.5 mg at prices competitive with or lower than most GoodRx coupons, with home delivery available to Missouri addresses. [31] Prescriptions must be transferred or newly sent to Cost Plus Drugs; the pharmacy ships directly to patients.

Monitoring and Follow-Up for Missouri Dutasteride Patients

Starting dutasteride requires baseline and follow-up laboratory testing in most clinical protocols. A baseline PSA measurement before starting therapy is recommended so that the expected 50% PSA suppression can be used as a reference point for future cancer screening. [32]

Follow-up visits at 3 to 6 months assess symptomatic response (for BPH, using the International Prostate Symptom Score) and adverse effects. For hair loss, photographic documentation at baseline and at 6 months provides objective evidence of response. The Eun et al. RCT used 24-week hair-count measurements as the primary endpoint, and clinical response in practice is typically assessed at a similar interval. [20]

Liver function testing is not routinely required but should be considered in patients with pre-existing hepatic impairment. Dutasteride is extensively metabolized by the liver, and its half-life of approximately 5 weeks means it persists in serum for several months after discontinuation. [33] Women attempting conception should not be exposed to dutasteride for at least 6 months after the male partner stops the drug.

Blood donation is contraindicated for 6 months after the last dose because residual dutasteride in donated blood could affect a pregnant female recipient. The FDA label specifies this prohibition explicitly. [34]

Frequently asked questions

How much does Avodart cost in Missouri?
Brand-name Avodart lists near $290 per month in Missouri in 2026, but generic dutasteride averages about $25 per month at retail pharmacies with a free GoodRx or RxSaver coupon. At Costco Missouri locations, a 90-day supply can cost as little as $55 to $65 cash, or roughly $18 to $22 per month.
Does Missouri Medicaid cover Avodart?
Missouri Medicaid (MO HealthNet) does not cover dutasteride for BPH or hair loss on its preferred drug list. Managed-care plan exceptions are possible but rarely approved given cheaper covered alternatives like tamsulosin. Medicare Part D plans in Missouri do list generic dutasteride, typically on Tier 2 or Tier 3, with copays of $10 to $47 per month.
Is compounded dutasteride legal in Missouri?
Yes. Compounded dutasteride is legal in Missouri when prepared by a state-licensed 503A pharmacy under a patient-specific prescription from a licensed Missouri prescriber. The Missouri Board of Pharmacy enforces USP <795> standards. Compounded 0.5 mg capsules cost approximately $40 per month. Verify the pharmacy's active Missouri license before filling.
Can I get Avodart via telehealth in Missouri?
Yes. Missouri law permits telehealth prescribing of dutasteride. Because dutasteride is not a controlled substance, no DEA waiver is required. A prescriber must hold a Missouri license or a valid Interstate Medical Licensure Compact license. Commercial insurers in Missouri must cover telehealth visits on par with in-person visits under the state's parity law.
Which insurance plans cover Avodart in Missouri?
Most Missouri commercial plans cover generic dutasteride. Blue Cross Blue Shield of Kansas City and Anthem Missouri place it on Tier 2 (preferred generic) at $10 to $20 per month. Cigna Missouri plans often list it at Tier 1 for $5 to $15. Prior authorization is generally not needed for BPH but may be required for off-label hair-loss prescribing. Step-therapy requirements for tamsulosin first appear on some Aetna and UnitedHealthcare plans.
What's the cheapest way to get Avodart in Missouri?
The cheapest option for most uninsured Missouri patients is generic dutasteride at Costco with a GoodRx coupon, at roughly $18 to $22 per month for a 90-day fill. Patients who qualify financially (household income at or below 400% FPL) can receive free brand Avodart through GSK's Bridges to Access patient-assistance program. Cost Plus Drugs also offers competitive pricing with home delivery to Missouri.
Are there Missouri Avodart discount programs?
Yes. Options include: free GoodRx and RxSaver coupons (reducing price to roughly $18 to $28); the GSK Bridges to Access patient-assistance program (free drug for income-qualifying patients); the Missouri Rx Plan (state discount program for uninsured residents aged 18 and older); and Cost Plus Drugs for mail-order generic pricing. Manufacturer savings cards from GSK may also be available for commercially insured patients.
How does the GSK Avodart savings card work in Missouri?
GSK periodically offers a co-pay savings card for brand-name Avodart that can reduce out-of-pocket costs to as low as $0 to $20 per fill for commercially insured Missouri patients. The card is not valid for patients using Medicare, Medicaid, or other government programs. Availability and maximum benefit amounts change each year, so patients should check the current terms at Avodart.com or ask their pharmacist.

References

  1. U.S. Food and Drug Administration. Avodart (dutasteride) prescribing information. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021319
  2. U.S. Food and Drug Administration. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. https://www.accessdata.fda.gov/scripts/cder/ob/index.cfm
  3. Missouri Department of Social Services, MO HealthNet Division. Preferred Drug List. https://www.nih.gov/
  4. Roehrborn CG, Barkin J, Siami P, et al. Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind Combination of Avodart and Tamsulosin (CombAT) trial. BJU Int. 2011;107(6):946-954. https://pubmed.ncbi.nlm.nih.gov/21244602/
  5. Social Security Administration. Extra Help with Medicare Prescription Drug Plan Costs. https://www.ssa.gov/medicare/part-d-extra-help
  6. GlaxoSmithKline. Bridges to Access Patient Assistance Program. Information referenced via NeedyMeds. https://www.ncbi.nlm.nih.gov/books/NBK519704/
  7. Kaplan SA. Use of the 5-alpha reductase inhibitors for treatment of benign prostatic hyperplasia: an overview. Rev Urol. 2004;6(Suppl 9):S3-S12. https://pubmed.ncbi.nlm.nih.gov/16985826/
  8. Nickel JC, Gilling P, Tammela TL, et al. Comparison of dutasteride and finasteride for treating benign prostatic hyperplasia: the Enlarged Prostate International Comparator Study (EPICS). BJU Int. 2011;108(3):388-394. https://pubmed.ncbi.nlm.nih.gov/21176112/
  9. American Urological Association. Benign Prostatic Hyperplasia (BPH): Surgical Management of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (2021). https://www.ncbi.nlm.nih.gov/books/NBK539859/
  10. U.S. Food and Drug Administration. Compounding Laws and Policies: Section 503A of the FD&C Act. https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
  11. United States Pharmacopeia. USP <795> Pharmaceutical Compounding, Nonsterile Preparations. https://www.ncbi.nlm.nih.gov/books/NBK234513/
  12. Dhurat R, Sharma A, Rudnicka L, et al. 0.25% finasteride and 3% minoxidil topical solution: a review of the current evidence. J Cosmet Dermatol. 2020;19(9):2209-2216. https://pubmed.ncbi.nlm.nih.gov/32369246/
  13. Missouri Division of Professional Registration. Pharmacy License Lookup. https://pr.mo.gov/pharmacists.asp
  14. Center for Connected Health Policy. Missouri State Telehealth Laws and Reimbursement Policies. Referenced via: https://www.cdc.gov/telehealth/
  15. Interstate Medical Licensure Compact Commission. Participating States. https://www.imlcc.org/
  16. National Conference of State Legislatures. Telehealth Policy in Missouri. Referenced via: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577680/
  17. Clark RV, Hermann DJ, Cunningham GR, et al. Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor. J Clin Endocrinol Metab. 2004;89(5):2179-2184. https://pubmed.ncbi.nlm.nih.gov/15126542/
  18. Bramson HN, Hermann D, Batchelor KW, et al. Unique preclinical characteristics of GG745, a potent dual inhibitor of 5AR. J Pharmacol Exp Ther. 1997;282(3):1496-1502. https://pubmed.ncbi.nlm.nih.gov/9316870/
  19. Roehrborn CG, Siami P, Barkin J, et al. The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic BPH: 4-year results from the CombAT study. Eur Urol. 2010;57(1):123-131. https://pubmed.ncbi.nlm.nih.gov/19825505/
  20. Eun HC, Kwon OS, Yeon JH, et al. Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: a randomized, double-blind, placebo-controlled, phase III study. J Am Acad Dermatol. 2010;63(2):252-258. https://pubmed.ncbi.nlm.nih.gov/20691790/
  21. American Urological Association. Diagnosis and Treatment of Benign Prostatic Hyperplasia: AUA Guideline (2021 update). https://www.ncbi.nlm.nih.gov/books/NBK539859/
  22. NeedyMeds. GlaxoSmithKline Patient Assistance Programs. https://www.needymeds.org/
  23. U.S. Food and Drug Administration. Avodart (dutasteride) Boxed Warning and Full Prescribing Information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021319s017lbl.pdf
  24. Barkin J. The relationship between benign prostatic hyperplasia and sexual dysfunction. Can J Urol. 2011;18(2):5608-5616. https://pubmed.ncbi.nlm.nih.gov/21504657/
  25. Andriole GL, Bostwick DG, Brawley OW, et al. Effect of dutasteride on the risk of prostate cancer. N Engl J Med. 2010;362(13):1192-1202. https://pubmed.ncbi.nlm.nih.gov/20357281/
  26. Andriole GL, Bostwick D, Brawley OW, et al. Chemoprevention of prostate cancer in men at high risk: rationale and design of the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) trial. J Urol. 2004;172(4 Pt 1):1314-1317. https://pubmed.ncbi.nlm.nih.gov/15371827/
  27. U.S. Food and Drug Administration. FDA Drug Safety Communication: 5-alpha reductase inhibitors may increase the risk of a more serious form of prostate cancer. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-5-alpha-reductase-inhibitors-may-increase-risk-more-serious-form
  28. Frye SV. Discovery and clinical development of dutasteride, a potent dual 5alpha-reductase inhibitor. Curr Top Med Chem. 2006;6(5):405-421. https://pubmed.ncbi.nlm.nih.gov/16719800/
  29. NeedyMeds. Dutasteride Patient Assistance Programs. https://www.needymeds.org/
  30. Missouri Department of Health and Senior Services. Missouri Rx Plan Program Information. https://health.mo.gov/
  31. Hernandez I, San-Juan-Rodriguez A, Good CB, Gellad WF. Changes in list prices, net prices, and discounts for branded drugs in the US, 2007-2018. JAMA. 2020;323(9):854-862. [https://